Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
July 1, 1987
The effects of N,N-diethyl-4-methyl-3-oxo-4-aza-5 alpha-androstane-17 beta-carboxamide, a 5 alpha-reductase inhibitor and antiandrogen, on the development of baldness in the stumptail macaque
R S Rittmaster, H Uno, M L Povar, et al.
The Prostate
|
January 13, 2004
Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line
C B Lazier, L N Thomas, R C Douglas, et al.
The Journal of Clinical Investigation
|
December 1, 1996
Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat
A S Wright, L N Thomas, R C Douglas, et al.
The Prostate
|
January 1, 1987
The effect of 4MA, a potent inhibitor of 5 alpha-reductase, on the growth of androgen-responsive human genitourinary tumors grown in athymic nude mice
G L Andriole, R S Rittmaster, D L Loriaux, et al.
Urology
|
September 8, 2004
Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia
G L Andriole, C Roehrborn, C Schulman, et al.
Molecular Endocrinology (Baltimore, Md.)
|
July 1, 1991
Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate
R S Rittmaster, K E Magor, A P Manning, et al.
Journal of Steroid Biochemistry
|
July 4, 1990
Synthesis of new steroid haptens for radioimmunoassay--VIII. Development and validation of a specific radioimmunoassay for serum 5 alpha-androstane-3 alpha, 17 beta-diol 17-glucuronide
D L Thompson, R S Rittmaster, A M Rodriguez, et al.
Prostate Cancer and Prostatic Diseases
|
June 29, 2011
Diabetes and prostate cancer risk in the REDUCE trial
C Wu, D M Moreira, L Gerber, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1991
Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects
D P Lookingbill, L M Demers, C Wang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1992
Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men
R S Rittmaster, A Lemay, H Zwicker, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
The Journal of Clinical Endocrinology and Metabolism
|
July 1, 1987
The effects of N,N-diethyl-4-methyl-3-oxo-4-aza-5 alpha-androstane-17 beta-carboxamide, a 5 alpha-reductase inhibitor and antiandrogen, on the development of baldness in the stumptail macaque
R S Rittmaster, H Uno, M L Povar, et al.
The Prostate
|
January 13, 2004
Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line
C B Lazier, L N Thomas, R C Douglas, et al.
The Journal of Clinical Investigation
|
December 1, 1996
Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat
A S Wright, L N Thomas, R C Douglas, et al.
The Prostate
|
January 1, 1987
The effect of 4MA, a potent inhibitor of 5 alpha-reductase, on the growth of androgen-responsive human genitourinary tumors grown in athymic nude mice
G L Andriole, R S Rittmaster, D L Loriaux, et al.
Urology
|
September 8, 2004
Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia
G L Andriole, C Roehrborn, C Schulman, et al.
Molecular Endocrinology (Baltimore, Md.)
|
July 1, 1991
Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate
R S Rittmaster, K E Magor, A P Manning, et al.
Journal of Steroid Biochemistry
|
July 4, 1990
Synthesis of new steroid haptens for radioimmunoassay--VIII. Development and validation of a specific radioimmunoassay for serum 5 alpha-androstane-3 alpha, 17 beta-diol 17-glucuronide
D L Thompson, R S Rittmaster, A M Rodriguez, et al.
Prostate Cancer and Prostatic Diseases
|
June 29, 2011
Diabetes and prostate cancer risk in the REDUCE trial
C Wu, D M Moreira, L Gerber, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1991
Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects
D P Lookingbill, L M Demers, C Wang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1992
Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men
R S Rittmaster, A Lemay, H Zwicker, et al.
Page
of 7